Christian Heiss: A Practical Synthesis on Peripheral Artery Disease in the Legs
Christian Heiss, Associate Head of Medical School (Research and Innovation) at the University of Surrey, Professor and NHS Consultant in Interventional Cardiovascular Medicine, shared a post on LinkedIn:
”New NEJM Clinical Practice review on PAD in the legs (McDermott).
A really practical synthesis that reinforces a few key points:
- PAD remains common and functionally limiting, with diagnosis still anchored around ABI <0.90. My take: Using quantitative Doppler waveform analysis.
- Event prevention is ‘full-spectrum’: intensive lipid-lowering (statins), antiplatelet therapy / low-dose aspirin + rivaroxaban (where appropriate), BP <130/80, and in relevant patients GLP-1RA (semaglutide) and SGLT2 inhibitors.
- For symptoms, supervised or structured home-based walking exercise remains foundational; revascularisation is best reserved for persistent symptoms not responding to exercise.
- Worth a read for anyone building PAD pathways across primary care/CDC and vascular services.”
Title: Peripheral Artery Disease in the Legs
Author: Mary M. McDermott
Read the Full Article on NEJM Clinical Practice
Title: Prognostic and predictive value of ultrasound-based estimated ankle brachial pressure index at early follow-up after endovascular revascularization of chronic limb-threatening ischaemia: a prospective, single-centre, service evaluation
Authors: Alexander D Rodway, Lydia Hanna, Jenny Harris, Rachael Jarrett, Charlotte Allan, Felipe Pazos Casal, Benjamin C T Field, Martin B Whyte, Nikolaos Ntagiantas, Ivan Walton, Ajay Pankhania, Simon S Skene, Gary D Maytham, Christian Heiss
Read the Full Article on eClinicalMedicine
Stay updated with Hemostasis Today.
-
Feb 4, 2026, 16:55Bhavesh Thakkar: The Most Dangerous Assumption About Aspirin Is That It’s “Simple”
-
Feb 4, 2026, 16:40Sonal Sonu: Why Incompatible Plasma Can Cause More Severe Reactions Than Incompatible Red Cells
-
Feb 4, 2026, 16:26Ahmad Ibrahim Ahmad Zainuddin: Aspirin in Primary Prevention Is Now a Carefully Selected Exception
-
Feb 4, 2026, 16:14Kapka Miteva: Why Sex and Gender Matter in Ischemic Heart Disease
-
Feb 4, 2026, 16:11Desapriya Ediriweera: Aspirin and Cancer Prevention – Time to Update the Story
-
Feb 4, 2026, 13:42David Lloyd: Thanks Lisa Murphy for Your Leadership
-
Feb 4, 2026, 13:21Aleksandar Sič: Happy to Have 2 Abstracts Published in Stroke
-
Feb 4, 2026, 12:44Donovan Sandoval: Honored to Serve as President of Strides for Strokes
-
Feb 4, 2026, 12:34Owen McCarty: Our Recent Study on The Pathogenic Effects of Anthrax Infection